BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3609485)

  • 1. Antithrombin III deficiency: clinical relevance and replacement therapy.
    Gallus AS
    Dev Biol Stand; 1987; 67():59-66. PubMed ID: 3609485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.
    Büller HR; ten Cate JW
    Am J Med; 1989 Sep; 87(3B):44S-48S. PubMed ID: 2679070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antithrombin III deficiency as a risk factor in postoperative thrombosis].
    Van Betsbrugge M
    Acta Chir Belg; 1985; 85(5):299-302. PubMed ID: 4082851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use.
    Werner MJ
    J Adolesc Health; 1995 Sep; 17(3):189-92. PubMed ID: 8519788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
    Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
    Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antithrombin III. Physiologic, physiopathologic and laboratory aspects].
    de Sousa JC; Ferreira R; Carriço F; Nunes V; Geraldes MJ; Parreira F; Ribeiro C
    Rev Port Cardiol; 1991 Sep; 10(9):693-9. PubMed ID: 1747261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III concentrates--are they clinically useful?
    Lechner K; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):340-8. PubMed ID: 7667814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
    Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial deficiency of antithrombin III].
    Coget JM; Dendien-Bernard S; Dupuis-Cuny C
    Phlebologie; 1987; 40(2):381-91. PubMed ID: 3615614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antithrombin III in hip surgery].
    Weber U; Schöndorf TH; Rettig H
    Z Orthop Ihre Grenzgeb; 1984; 122(1):16-9. PubMed ID: 6702257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
    von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of antithrombin III concentrates].
    Vinazzer H
    Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K
    Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxymetholone therapy in patients with familial antithrombin III deficiency.
    Shibuya A; Ninomiya H; Nakazawa M; Nagasawa T; Yoda Y; Abe T
    Thromb Haemost; 1988 Dec; 60(3):495-7. PubMed ID: 3238652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis].
    Schoch U; Zanetti E; von Felten A
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1807-10. PubMed ID: 2962279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
    Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perioperative plasma antithrombin activity with "low-dose" heparin prophylaxis. Perioperatively acquired antithrombin III deficiency as a cause for the failure of heparin prophylaxis?].
    Kussmann J; Hirche H; Sengupta R
    Dtsch Med Wochenschr; 1983 Mar; 108(12):449-52. PubMed ID: 6832015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acquired antithrombin III deficiency].
    Müller G
    Z Gesamte Inn Med; 1992 Feb; 47(2):74-7. PubMed ID: 1585693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome.
    Vaziri ND; Paule P; Toohey J; Hung E; Alikhani S; Darwish R; Pahl MV
    Arch Intern Med; 1984 Sep; 144(9):1802-3. PubMed ID: 6477000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AT III Barcelona: a familial quantitative-qualitative AT III deficiency.
    Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML
    Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.